| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |